IPO Alert: Influx Healthtech Opens June 18, GMP Predicts 41% Listing Gain; Should You Invest?

Influx Healthtech IPO will open for public subscription tomorrow, i.e., Wednesday, June 18. This SME IPO is expected to raise Rs 58.57 crore through a combination of fresh equity shares and an offer for sale (OFS). Influx HealthTech is a pharma company based in Mumbai, Maharashtra.

IPO Structure and Key Details

The Influx Healthtech IPO consists of a fresh issue of 50 lakh shares, aggregating up to ₹48 crore, and an offer for sale of 11 lakh shares, amounting to ₹10.56 crore. The shares will be listed on the NSE SME platform, catering primarily to small and medium investors. The book-building issue type allows investors to bid within a specified price range, offering flexibility in pricing.

Influx Healthtech IPO Subscription Window and Listing Timeline

The IPO will remain open for bidding from June 18 to June 20, 2025. The basis of allotment is likely to be finalised on June 23, and the stock is expected to be listed on June 25, 2025. Investors are advised to monitor official communication for confirmation on allotment status and listing timelines.

Price Band and Lot Size Explained

The price band for the Influx Healthtech IPO is set between Rs. 91 and Rs. 96 per share. Retail investors can bid for a minimum of 1 lot, which comprises 1,200 shares, translating to a minimum investment of Rs. 1,09,200.

What Does GMP Suggest?

The latest update from the grey market shows that the Influx Healthtech IPO GMP is Rs. 40 (as per Investorgain as of June 17, 2:55 PM). The estimated listing price for the IPO is expected to be Rs. 136 with potential gains of 41.67%.

Should You Apply?

While detailed financials and fundamentals are awaited, the company's focus on technological solutions in healthcare may appeal to growth-orientated investors. Potential investors should read the Red Herring Prospectus thoroughly and check the company's valuation and business model before applying.

About Influx Healthtech Limited

Founded in 2003 as a micro-scale manufacturing unit, Influx Healthtech Limited operates in the healthcare manufacturing sector. The company operates GMP, HACCP, ISO 22000, and Halal-certified facilities equipped with advanced machinery, a dedicated quality control department, and skilled manpower. Influx Healthtech has clientele across India and four continents. Its core business revolves around contract manufacturing of nutraceuticals, cosmetics, Ayurvedic and herbal products, veterinary feed supplements, and homecare items.

Disclaimer: The views and recommendations expressed are solely those of the individual analysts or entities and do not reflect the views of GoodReturns.in or Greynium Information Technologies Private Limited (together referred as “we”). We do not guarantee, endorse or take responsibility for the accuracy, completeness or reliability of any content, nor do we provide any investment advice or solicit the purchase or sale of securities. All information is provided for informational and educational purposes only and should be independently verified from licensed financial advisors before making any investment decisions.